Liminatus Pharma, Inc.

Liminatus Pharma, Inc. financial statements

Liminatus Pharma, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 0EODHD
Net income−USD 10.21M10-K
Cash and equivalentsUSD 337.65K10-Q
Total debtUSD 1.44MEODHD

Liminatus Pharma, Inc. financials on 6ix · Liminatus Pharma, Inc. on 6ix